Campbell & Co Investment Adviser’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-324,585
| Closed | -$1.06M | – | 1164 |
|
2024
Q2 | $1.06M | Buy |
+324,585
| New | +$1.06M | 0.09% | 340 |
|
2023
Q2 | – | Sell |
-59,651
| Closed | -$340K | – | 961 |
|
2023
Q1 | $340K | Buy |
59,651
+9,929
| +20% | +$56.6K | 0.06% | 564 |
|
2022
Q4 | $502K | Buy |
49,722
+35,290
| +245% | +$356K | 0.12% | 313 |
|
2022
Q3 | $323K | Buy |
+14,432
| New | +$323K | 0.07% | 457 |
|